Growth Metrics

Nephros (NEPH) Change in Receivables (2016 - 2025)

Nephros has reported Change in Receivables over the past 16 years, most recently at -$247000.0 for Q4 2025.

  • Quarterly results put Change in Receivables at -$247000.0 for Q4 2025, down 374.44% from a year ago — trailing twelve months through Dec 2025 was $633000.0 (up 122.11% YoY), and the annual figure for FY2025 was $633000.0, up 122.11%.
  • Change in Receivables for Q4 2025 was -$247000.0 at Nephros, down from $621000.0 in the prior quarter.
  • Over the last five years, Change in Receivables for NEPH hit a ceiling of $896000.0 in Q1 2025 and a floor of -$756000.0 in Q3 2022.
  • Median Change in Receivables over the past 5 years was $36000.0 (2023), compared with a mean of $53000.0.
  • Biggest five-year swings in Change in Receivables: plummeted 539.53% in 2022 and later soared 3972.73% in 2025.
  • Nephros' Change in Receivables stood at $87000.0 in 2021, then plummeted by 201.15% to -$88000.0 in 2022, then soared by 156.82% to $50000.0 in 2023, then surged by 80.0% to $90000.0 in 2024, then tumbled by 374.44% to -$247000.0 in 2025.
  • The last three reported values for Change in Receivables were -$247000.0 (Q4 2025), $621000.0 (Q3 2025), and -$637000.0 (Q2 2025) per Business Quant data.